Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New inhalation anesthetics]

P Conzen1, M Nuscheler

  • 1Institut für Anästhesiologie der Ludwig-Maximilians-Universität München, Klinikum Grosshadern.

Der Anaesthesist
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Serum heparan sulfate levels are elevated in endotoxemia.

European journal of medical research·2021
Same author

Application of the Bogossian formula for evaluation of the QT interval in pacemaker patients with stimulated left bundle branch block.

Clinical research in cardiology : official journal of the German Cardiac Society·2018
Same author

No effect of the cyclooxygenase-2 inhibitor etoricoxib on pre-emptive and post-operative analgesia in visceral surgery: results of a randomized controlled trial.

European journal of pain (London, England)·2015
Same author

Placental syncytiotrophoblast maintains a specific type of glycocalyx at the fetomaternal border: the glycocalyx at the fetomaternal interface in healthy women and patients with HELLP syndrome.

Reproductive sciences (Thousand Oaks, Calif.)·2013
Same author

Increased serum concentrations of circulating glycocalyx components in HELLP syndrome compared to healthy pregnancy: an observational study.

Reproductive sciences (Thousand Oaks, Calif.)·2012
Same author

Shedding of the coronary endothelial glycocalyx: effects of hypoxia/reoxygenation vs ischaemia/reperfusion.

British journal of anaesthesia·2011
Same journal

[Promoting young academics in anesthesiology: factors for an attractive internship].

Der Anaesthesist·2022
Same journal

[Respiratory support in COVID-19: all in due time!]

Der Anaesthesist·2022
Same journal

[Noninvasive respiratory support and invasive ventilation in COVID‑19 : Where do we stand today?]

Der Anaesthesist·2022
Same journal

[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Der Anaesthesist·2022
Same journal

[Anesthesia in patients with acute porphyria].

Der Anaesthesist·2022
Same journal

[Quality and safe anesthesia for all children : That is their right!]

Der Anaesthesist·2022
See all related articles

New volatile anesthetics, sevoflurane and desflurane, offer faster recovery and easier dose titration due to low blood solubility. Sevoflurane has advantages like pleasant odor, while desflurane is not recommended for induction, especially in children.

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Two novel halogenated volatile anesthetics, sevoflurane and desflurane, have been introduced.
  • These agents possess low blood solubility, differentiating them from existing inhaled anesthetics.

Purpose of the Study:

  • To evaluate the pharmacokinetic and pharmacodynamic properties of sevoflurane and desflurane.
  • To compare their clinical efficacy and safety profiles with established anesthetics.

Main Methods:

  • Extensive clinical and experimental evaluations were conducted.
  • Pharmacokinetic and pharmacodynamic data were analyzed.

Main Results:

  • Both sevoflurane and desflurane demonstrate superior pharmacokinetic properties, enabling faster emergence and recovery from anesthesia.

Related Experiment Videos

  • Sevoflurane offers advantages such as a pleasant odor and minimal airway irritation, with cardiovascular stability comparable to isoflurane.
  • Desflurane exhibits minimal metabolism, but potential side effects include airway irritation and CO2 release from absorbents. It is not recommended for anesthesia induction, particularly in children, and its use is limited in cardiac patients due to sympathetic stimulation.

    • Conclusions:

    • Sevoflurane and desflurane represent advancements in inhaled anesthesia, offering improved patient recovery.
    • While sevoflurane shows a favorable profile, potential nephrotoxicity from metabolism requires monitoring.
    • Desflurane's properties necessitate careful patient selection and administration, especially regarding airway effects and cardiovascular stability.